Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial

por Katsambas, Andreas, Peris, Ketty, Vena, Gino, Freidmann, Peter, Wozel, Gottfried, Daudén, Esteban, Licu, Daiana, Placchi, Mauro, De La Brassinne, Michel
Publicado 2009

Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study

por Ghislain, Pierre-Dominique, Lambert, Jo, Lam Hoai, Xuãn-Lan, Hillary, Tom, Roquet-Gravy, Pierre-Paul, de la Brassinne, Michel, Segaert, Siegfried
Publicado 2023

Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study

por Ghislain, Pierre-Dominique, Lambert, Jo, Lam Hoai, X. L., Hillary, Tom, Roquet-Gravy, Pierre-Paul, de la Brassinne, Michel, Segaert, Siegfried
Publicado 2022

Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study

por Ghislain, Pierre-Dominique, Failla, Valérie, Lambert, Jo, Soenen, Rani, Grine, Lynda, Tannous, Julio, Guiot, Françoise, Willaert, Fabienne, Fierens, Hugues, Vandaele, Mark, Boonen, Hugo, Saerens, Julie, Meuleman, Véronique, Stockman, Annelies, Belpaire, Arno, Swimberghe, Sandra, Temmerman, Linda, Dekeyser, Sam, Lambert, Jean-Michel, de Schaetzen, Virginie, de la Brassinne, Michel, Benhadou, Farida
Publicado 2021